CFL1 and major depressive disorder: GluN2B selective inhibitor and partial agonist of GluN2B-containing receptors reversed the abnormality in cofilin signaling, spine density, as well as several behavioral phenotypes including depression-like behavior, repetitive behavior and social deficit in GluD1 KO21,26.